MAP to Provide Access to Nilotinib, for Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Condition:   Acute Lymphoblastic Leukemia (ALL) Intervention:   Drug: Nilotinib Sponsor:   Novartis Pharmaceuticals Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2020 Category: Research Source Type: clinical trials

Nilotinib, for Patients With CML-CP, CML-AP, or CML-BC
Condition:   Chronic Myelogenous Leukemia (CML) Intervention:   Drug: Nilotinib Sponsor:   Novartis Pharmaceuticals Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

MAP to Provide Access to Nilotinib, for Patients With HES
Condition:   Hypereosinophilic Syndrome (HES) Intervention:   Drug: Nilotinib Sponsor:   Novartis Pharmaceuticals Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2020 Category: Research Source Type: clinical trials

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Condition:   Neoplasms Intervention:   Drug: Nilotinib and Paclitaxel Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2020 Category: Research Source Type: clinical trials

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Condition:   Neoplasms Interventions:   Drug: Nilotinib;   Drug: Paclitaxel Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2020 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin
Condition:   Healthy Interventions:   Drug: Metformin;   Drug: Metformin + Nilotinib Sponsor:   Hyewon Chung Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2020 Category: Research Source Type: clinical trials

Effects of Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
Condition:   Patients Diagnosed as Chronic Meyloid Leukemia Intervention:   Drug: Tyrosine kinase Inhibitors (Imatinib& Nilotinib) Sponsor:   Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2020 Category: Research Source Type: clinical trials

Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer
Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage IA Breast Cancer AJCC v8;   Anatomic Stage IB Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIA Breast Cancer AJCC v8;   Anatomic Stage IIB Breast Cancer AJCC v8 ;   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJC...
Source: ClinicalTrials.gov - December 20, 2019 Category: Research Source Type: clinical trials